These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 942453)

  • 1. Hypolipidemic activity of 2,8-dibenzyl-cyclooctanone in rats.
    Cayen MN; Dubuc J; Dvornik D
    Biochem Pharmacol; 1976 Jul; 25(13):1537-41. PubMed ID: 942453
    [No Abstract]   [Full Text] [Related]  

  • 2. Cycloalkanones. 6. Separation of hypocholesterolemic and antifertility activities in derivatives of 2,8-dibenzylcyclooctanone.
    Carlson GL; Hall IH; Piantadosi C
    J Med Chem; 1975 Apr; 18(4):432-4. PubMed ID: 1121011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloalkanones. 3. Structure-activity relationships of hypocholesterolemic cyclooctanone derivatives.
    Carlson GL; Hall IH; Abernethy GS; Piantadosi C
    J Med Chem; 1974 Feb; 17(2):154-7. PubMed ID: 4809249
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the hypolipdemic and estrogenic activities of 2,8-dibenzylcyclooctanone and its analogues.
    Cayen MN; Dubuc J; Givner ML; Greselin E; Revesz C
    Biochem Pharmacol; 1976 Jul; 25(13):1543-4. PubMed ID: 942454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 6. Cycloalkanones. 7. Hypocholesterolemic activity of aliphatic compounds related to 2,8-dibenzylcyclooctanone.
    Carlson GL; Hall IH; Piantadose C
    J Med Chem; 1975 Oct; 18(10):1024-6. PubMed ID: 1159681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycloalkanones. 2. Synthesis and biological activity of alpha, alpha'-dibenzylcycloalkanones.
    Piantadosi C; Hall IH; Irvine JL; Carlson GL
    J Med Chem; 1973 Jul; 16(7):770-5. PubMed ID: 4725922
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased plasma cholesterol and decreased body lipid levels in Wistar rats following pirinixil (BR 931) treatment.
    Kritchevsky D; Klurfeld DM; Tepper SA; Mueller MA; Puglisi L; Sirtori CR
    Pharmacol Res Commun; 1979 Jun; 11(6):475-82. PubMed ID: 504321
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.
    Baggaley KH; Fears R; Hindley RM; Morgan B; Murrell E; Thorne DE
    J Med Chem; 1977 Nov; 20(11):1388-93. PubMed ID: 915898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
    Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
    Digestion; 1979; 19(4):228-36. PubMed ID: 478204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term administration of different alcoholic beverages to rats on liver lipid metabolism and bile acid conjugation.
    Jordö L; Olsson R; Scherstéin T
    Digestion; 1974; 11(3-4):183-93. PubMed ID: 4448318
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of prolonged fasting and of glucose refeeding on rat serum and liver lipid levels.
    Kerpel S; Rubenstein B; Rubinstein D
    Lipids; 1971; 6(5):332-40. PubMed ID: 5096593
    [No Abstract]   [Full Text] [Related]  

  • 13. Cycloalkanones V: synthesis, distribution, and effects on triglyceride metabolism.
    Hall IH; Lamb RG; Mar MH; Carlson GL; Piantadosi C
    J Pharm Sci; 1975 Feb; 64(2):35-40. PubMed ID: 165282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of decamethoxine, decamine and levorin on the content of cholesterol, phospholipids and triglycerides in albino rat liver].
    Kovtuniak NA; Bordiakovskaia LG; Stadniĭchuk RF
    Farmakol Toksikol; 1983; 46(5):72-5. PubMed ID: 6628663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
    Maier R; Muller K
    Adv Exp Med Biol; 1975; 63():349-57. PubMed ID: 1199873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of four agents (tibric acid, DH 990, oxandrolone and Sch 9122) on aspects of lipid metabolism in rats).
    Kritchevsky D; Tepper SA; Story JA
    Arzneimittelforschung; 1976; 26(5):862-4. PubMed ID: 989359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine modulates hepatic lipid accumulation in alcohol-induced liver injury.
    Senthilkumar R; Viswanathan P; Nalini N
    Pol J Pharmacol; 2003; 55(4):603-11. PubMed ID: 14581719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a terminal period of fasting on the serum and tissue lipid effects of ethyl chlorophenoxyisobutyrate (CPIB).
    Duncan CH; Best MM
    Metabolism; 1968 Aug; 17(8):681-9. PubMed ID: 5676214
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study on hypolipidemic activities of high and low molecular weight chitosan in rats.
    Zhang J; Zhang W; Mamadouba B; Xia W
    Int J Biol Macromol; 2012 Nov; 51(4):504-8. PubMed ID: 22728057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic action of a new aryloxy compound (S-8527) in rats.
    Toki K; Nakamura Y; Agatsuma K; Nakatani H; Aono S
    Atherosclerosis; 1973; 18(1):101-8. PubMed ID: 4741527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.